The recommendations address organized and sanctioned competitive sports participation.
- Young trained athletes with underlying cardiovascular abnormalities are at an increased risk for sudden cardiac death.
- Considerations such as protection of the athlete’s health and avoidance of an unreasonable risks for sudden death during competitive athletics are stressed when addressing medical eligibility versus disqualification decisions, which have become increasingly complex.
Read the full Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities articles in Circulation
- Preamble: Principles, and General Considerations
- Task Force 1: Classification of Sports: Dynamic, Static and Impact
- Task Force 2: Preparticipation Screening for Cardiovascular Disease in Competitive Athletes
- Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis
- Task Force 4: Congenital Heart Disease
- Task Force 5: Valvular Heart Disease
- Task Force 6: Hypertension
- Task Force 7: Aortic Diseases, Including Marfan Syndrome
- Task Force 8: Coronary Artery Disease
- Task Force 9: Arrhythmias and Conduction Defects
- Task Force 10: The Cardiac Channelopathies
- Task Force 11: Drugs and Performance Enhancing Substances
- Task Force 12: Emergency Action Plans, Resuscitation, CPR, and AEDs
- Task Force 13: Commotio Cordis
- Task Force 14: Sickle Cell Trait
- Task Force 15: Legal Aspects of Medical Eligibility and Disqualification Recommendations
Recommendations for Competitive Athletes With Cardiovascular Abnormalities
Douglas Zipes, MD, coauthor of the Scientific Statement from the American Heart Association on "Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities," outlines some of the changes in this new update and the reasoning behind them.